| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.33 | 3e-13 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.26 | 1e-09 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-09 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.26 | 2e-08 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-07 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.24 | 3e-07 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-07 |